Emergent BioSolutions to sell Baltimore-Bayview manufacturing site for $36.5M

Emergent BioSolutions to sell Baltimore-Bayview manufacturing site for $36.5M

Submitted by admin on March 10, 2025 - 11:11pm
Source: 
MSN/Seeking Alpha
News Tags: 
Emergent BioSolutions
Baltimore
drug manufacturing
CDMO
Syngene International
Headline: 
Emergent BioSolutions to sell Baltimore-Bayview manufacturing site for $36.5M
snippet: 

Emergent BioSolutions (NYSE:EBS) is selling its Baltimore-Bayview facility to contract research, development, and manufacturing organization Syngene International for $36.5M.

Do Not Allow Advertisers to Use My Personal information